ClinicalTrialsFinder
CompletedPhase 4ACTRN12608000251325

alpha lipoic acid in burning mouth syndrome:a randomized double-blind placebo-controlled crossover trial

The effect of alpha lipoic acid in the management of burning mouth syndrome

Sponsor

Fundacao de Amparo a Pesquisa do estado de sao paulo

Enrollment

31 participants

Start Date

Jun 25, 2006

Study Type

Interventional

Conditions

burning mouth syndrome

Summary

The purpose of this study was to evaluate the effectiveness of alpha lipoic acid as an alternative in the management of burning mouth syndrome

Eligibility

Sex: Both males and femalesMin Age: 30 Yearss

Plain Language Summary

Simplified for easier understanding

This trial tests whether alpha lipoic acid, a nutritional supplement, can help relieve the painful burning sensation in the mouth experienced by people with burning mouth syndrome. Participants must have had burning mouth symptoms for at least 6 months without any visible mouth sores or underlying medical conditions that could cause the burning.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

therapy with alpha lipoic acid orally, three capsules of 200 mg per day during 30 days There was a washout period of 20 days

therapy with alpha lipoic acid orally, three capsules of 200 mg per day during 30 days There was a washout period of 20 days

Locations(1)

Brazil

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000251325